Minggu, 16 Januari 2022

Bcrx Stock Forecast Zacks

Today, you can download 7 best stocks for the next 30 days. Four analysts have provided estimates for biocryst pharmaceuticals' earnings.


Analysts Estimate Biocryst Pharmaceuticals Bcrx To Report A Decline In Earnings What To Look Out For Nasdaq

Click to get this free report biocryst pharmaceuticals, inc.

Bcrx stock forecast zacks. Free stock analysis report to read this article on zacks.com click. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Free stock analysis report to read this article on zacks.com click.

So, this combination makes it difficult to conclusively predict that biocryst will beat the consensus eps estimate. (nasdaq:bcrx) will post sales of $46.56 million for the current fiscal quarter, zacks reports. Biocryst pharmaceuticals (bcrx) quote overview » estimates » biocryst pharmaceuticals.

Zacks' proprietary data indicates that biocryst pharmaceuticals, inc. The drugmaker posted revenue of $41 million in the period, beating street forecasts. Wall street analysts forecast that biocryst pharmaceuticals, inc.

Bxrx investment & stock information. The average price target is $21.67 with a high forecast of $30.00 and a low forecast of $16.00. Four analysts have provided estimates for biocryst pharmaceuticals' earnings, with the lowest sales estimate coming in at $42.00 million and the highest estimate coming in at $50.88 million.

On the other hand, the stock currently carries a zacks rank of #4. 17, 2021 at 7:21 a.m. (nasdaq:bcrx) will announce sales of $46.56 million for the current quarter, zacks reports.

View all zacks #1 ranked stocks. Volume has increased on the last day along with the price,. Get the latest baudax bio, inc.

Bottom 38% (157 out of 254) industry: Since then, bcrx stock has increased by 377.6% and is now trading at $12.37. This compares to loss of $0.24 per share a year ago.

Bcrx stock forecast our latest prediction for biocryst pharmaceuticals inc.'s stock price was made on the aug. Today, you can download 7 best stocks for the next 30 days. Sarepta therapeutics’ loss per share estimates have narrowed 31.3% for 2021 and 26% for 2022, over the past 60.

Four analysts surveyed by zacks expected $37.8 million. As of 2021 november 15, monday current price of bcrx stock is 12.120$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). Based on 10 wall street analysts offering 12 month price targets for biocryst in the last 3 months.

Wall street analysts forecast that biocryst pharmaceuticals, inc. 11, 2020 when the stock price was at 3.96$. The average price target represents a 38.38% change from the last price of $15.66.

Biocryst pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very. Hedge funds were also right about betting on bcrx as the stock returned 128.5% so far in q2 (through june 10th) and outperformed the market by an even larger margin. The highest sales estimate is $50.88 million and the lowest is $

Biocryst pharmaceuticals (bcrx) came out with a quarterly loss of $0.36 per share versus the zacks consensus estimate of a loss of $0.26. About the biocryst pharmaceuticals, inc. You can see the complete list of today’s zacks #1 rank (strong buy) stocks here.

Analyst price target on bcrx. Click to get this free report biocryst pharmaceuticals, inc. Biocryst pharmaceuticals stock price target raised to $15 from $10 at j.p.

Is currently rated as a zacks rank 3 and we are expecting an inline return from the bcrx shares relative to the market in the.


Biocryst Bcrx Begins Enrollment In Pnh Study On Bcx9930 Nasdaq


Biocryst Bcrx Begins Enrollment In Pnh Study On Bcx9930 Nasdaq


Should Value Investors Pick Crawford Company Crdb Stock


Biocryst Pharmaceuticals Inc Bcrx Page The Online Investor


Share:

0 komentar:

Posting Komentar

Labels

Blog Archive